AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Thyroid hormones (THs) are synthesized in the thyroid gland, and they circulate in the blood
to regulate cells, tissues, and organs in the body. In particular, they exert several effects on …

The ongoing pandemic of coronavirus disease-2019 (COVID-19) is being caused by severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The disease continues to present …

Background There is a critical need to better understand the mechanisms that drive local cell
invasion and metastasis to develop new therapeutics targeting metastatic disease …

Amiodarone hydrochloride is an antiarrhythmic drug, with proven efficacy in prevention and
treatment of numerous arrhythmias, atrial fibrillation especially, or ventricular arrhythmias …

Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with increased
cardiovascular morbidity and mortality. The pathophysiology of AF is characterized by …

Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular
and supraventricular arrhythmias, has been identified as a candidate drug for use against …

Oral amiodarone for 3–6 months is commonly required for the prevention and treatment of
atrial fibrillation (AF) after surgical ablation of refractory AF. However, clinical data show that …

For ethical, economical, and scientific reasons, animal experimentation, used to evaluate the
potential neurotoxicity of chemicals before their release in the market, needs to be replaced …

Background Because of its antiarrhythmic potency and due to the lack of alternatives,
amiodarone is often used for antiarrhythmic therapy in patients with implantable cardioverter …